Upgrade to SI Premium - Free Trial

Abivax (ABVX)

101.53 -3.40 (3.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/8/26 *Est.)

Latest Headlines

Wolfe flags a buying opportunity in this biotech stock June 5, 2026 11:00 AM - StreetInsider Abivax (ABVX) PT Lowered to $136 at Wolfe Research June 3, 2026 12:49 PM - StreetInsider Selloff in this major biotech stock is "overdone," BTIG says June 2, 2026 11:00 AM - StreetInsider Abivax (ABVX) PT Lowered to $132 at Morgan Stanley June 2, 2026 7:50 AM - StreetInsider Wedbush Upgrades Abivax (ABVX) to Neutral June 2, 2026 7:08 AM - StreetInsider Abivax (ABVX) PT Lowered to $135 at Truist Securities June 2, 2026 7:05 AM - StreetInsider Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data June 2, 2026 6:09 AM - StreetInsider Form 6-K Abivax S.A. For: Jun 01 June 2, 2026 6:08 AM - SEC Filing Abivax (ABVX) PT Raised to $187 at Citizens June 2, 2026 4:04 AM - StreetInsider Jefferies Downgrades Abivax (ABVX) to Hold June 2, 2026 1:03 AM - StreetInsider After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP June 1, 2026 4:37 PM - StreetInsider Abivax reports positive Phase 3 results for ulcerative colitis drug June 1, 2026 4:05 PM - StreetInsider Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis June 1, 2026 4:05 PM - Globe NewsWire Abivax (ABVX) Halted, News Pending June 1, 2026 4:03 PM - StreetInsider Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation May 28, 2026 8:35 AM - StreetInsider Abivax (ABVX) Reiterated at Market Outperform by Citizens on Open-label Results May 26, 2026 4:40 AM - StreetInsider Form 6-K Abivax S.A. For: Mar 31 May 22, 2026 4:13 PM - SEC Filing Abivax reports Q1 2026 results, obefazimod shows sustained remission May 22, 2026 4:05 PM - StreetInsider Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients May 22, 2026 4:05 PM - Globe NewsWire Form 6-K Abivax S.A. For: May 20 May 20, 2026 4:47 PM - SEC Filing Abivax Announces Results of its May 11, 2026 Annual General Meeting May 11, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I May 11, 2026 12:50 PM - SEC Filing Form 6-K Abivax S.A. For: May 07 May 7, 2026 4:04 PM - SEC Filing Form 424B7 Abivax S.A. May 7, 2026 11:33 AM - SEC Filing Abivax to Present Data on Obefazimod at Digestive Disease Week® April 22, 2026 4:05 PM - Globe NewsWire Form 6-K Abivax S.A. For: Apr 20 April 20, 2026 4:09 PM - SEC Filing Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents April 20, 2026 4:05 PM - Globe NewsWire Bernstein on US Pharma and Biotech: Who might buy whom? April 13, 2026 5:52 AM - StreetInsider Abivax files annual reports with French and US regulators April 1, 2026 4:06 PM - StreetInsider Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies April 1, 2026 4:05 PM - Globe NewsWire Abivax (ABVX) remains 'Best Idea' at Guggenheim following FY25 update March 24, 2026 10:45 AM - StreetInsider Truist on Abivax (ABVX): 'We continue to see a robust opportunity' March 24, 2026 9:01 AM - StreetInsider Abivax (ABVX) Reiterated at Market Outperform by Citizens Ahead of ABTECT-UC Results March 24, 2026 4:09 AM - StreetInsider Abivax (ABVX) PT Raised to $148 at Barclays March 24, 2026 2:15 AM - StreetInsider Form S-8 Abivax S.A. March 23, 2026 5:29 PM - SEC Filing Form 20-F Abivax S.A. For: Dec 31 March 23, 2026 4:56 PM - SEC Filing Form 6-K Abivax S.A. For: Dec 31 March 23, 2026 4:50 PM - SEC Filing Abivax Announces Full Year 2025 Financial Results and Provides Business Updates March 23, 2026 4:05 PM - Globe NewsWire Jefferies says these are the best SMID-cap biotech stocks to buy March 22, 2026 10:00 AM - StreetInsider Piper Sandler on Abivax (ABVX): 'We Remain Buyers' March 17, 2026 7:54 AM - StreetInsider Jefferies Starts Abivax (ABVX) at Buy March 16, 2026 12:58 AM - StreetInsider Full Article List